Disease/Infection News

RSS

Toilet flushing can create a cloud of virus-containing aerosol droplets

Researchers used a computer simulation to show how a flushing toilet can create a cloud of virus-containing aerosol droplets that is large and widespread and lasts long enough that the droplets could be breathed in by others.

16 Jun 2020

Study highlights vulnerability of people in refugee camps to COVID-19

A COVID-19 outbreak in a refugee settlement will likely overwhelm the available healthcare capacity and infrastructure and spread through nearly the entire settlement population if left unchecked, according to a new study published June 16 in PLOS Medicine by Paul Spiegel of Johns Hopkins University, United States, and colleagues.

16 Jun 2020

How novel coronavirus affects children

New insights into the clinical and epidemiological characteristics of pediatric patients with coronavirus disease 2019 (COVID-19) could facilitate early identification and intervention in suspected patients, according to a study publishing on June 16, 2020 in the open-access journal PLOS Medicine by Xihui Zhou of the First Affiliated Hospital of Xi'an Jiaotong University, China and colleagues.

16 Jun 2020

All of Us Research Program launches initiatives to seek new insights into COVID-19

The All of Us Research Program, part of the National Institutes of Health, today announced that it is leveraging its significant and diverse participant base to seek new insights into COVID-19--through antibody testing, a survey on the pandemic's impacts and collection of electronic health record information.

16 Jun 2020

Researchers receive federal funding to rapidly repurpose FDA-approved drugs for COVID-19

Researchers at the University of Maryland School of Medicine will be partnering on an agreement funded by the federal government's Defense Advanced Research Projects Agency (DARPA) to rapidly test hundreds of drugs, approved and marketed for other conditions, to see whether any can be repurposed to prevent or treat COVID-19.

16 Jun 2020

Antidepressant fluoxetine (Prozac) suppresses replication of SARS-CoV-2

A study conducted by researchers at Julius-Maximilians-Universität Würzburg has shown that the antidepressant agent fluoxetine may be an effective drug for the early treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among at-risk groups.

16 Jun 2020

Multi-institutional study examines neuroimaging findings in COVID-19 patients

A new multi-institutional study published in the journal Radiology identifies patterns in abnormal brain MRI findings in patients with COVID-19.

16 Jun 2020

Repeated coughing adversely affects filtering efficiency of face masks

Face masks are thought to slow the spread of viruses, including the novel coronavirus that causes COVID-19, but little is known about how well they work.

16 Jun 2020

Antibody cocktail with potential to treat COVID-19 identified

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

16 Jun 2020

New discovery could open door to next generation malaria vaccine

In an unprecedented first, scientists at Seattle Children's Research Institute have developed a genetically attenuated parasite (GAP) that arrests late in the liver stage of human malaria.

16 Jun 2020

22 nonprofit organizations funded to support the needs of families in response to COVID-19

Voices for Healthy Kids, an initiative of the American Heart Association -- the world's leading voluntary organization dedicated to a world of longer, healthier lives -- announced that 22 nonprofit organizations have been awarded COVID-19 Rapid Response Grants to support the needs of families in response to the pandemic.

16 Jun 2020

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.

16 Jun 2020

Researchers are strengthening the capacity to assess the risk of COVID-19 in Europe

As people in Europe emerge from COVID-19 lockdowns, a study has identified which countries have populations most at risk from the virus.

16 Jun 2020

Awareness campaign aims to alleviate unnecessary fears about calling 9-1-1 in pandemic

As new COVID-19 cases continue to rise in 22 states and strain emergency departments nationwide, the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) suggest ER visits in April were down 42% across the country compared to the same period last year.

16 Jun 2020

Life saving drug found for COVID-19 patients on ventilators

Results from Oxford University’s RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.

16 Jun 2020

Wealthy hospital taps small craft breweries for financial aid to buy masks, gloves

As Inova Health System sought donations in March to buy personal protective equipment for its staff to treat COVID-19, Zach Mote, a police officer turned brewer, came to their aid.

16 Jun 2020

Health experts link rise in Arizona COVID cases to end of stay-at-home order

With new daily coronavirus cases rising in at least two dozen states, an explosion of new infections in Arizona is stretching some hospitals and alarming public health experts who link the surge in cases to the state’s lifting of a stay-at-home order a month ago.

16 Jun 2020

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.

16 Jun 2020

Why improved pneumonia diagnosis is needed now more than ever

News-Medical speaks to Dr. William La Via about why improved pneumonia diagnosis is vital, especially in the wake of the COVID-19 pandemic.

16 Jun 2020

COVID-19 health crisis highlights food insecurity among children

One in four households with children have reported a child experiencing hunger as a result of the COVID-19 health crisis, according to the latest CUNY SPH COVID-19 tracking survey.

16 Jun 2020

Disease/Infection News

Toilet flushing can create a cloud of virus-containing aerosol droplets

Study highlights vulnerability of people in refugee camps to COVID-19

How novel coronavirus affects children

All of Us Research Program launches initiatives to seek new insights into COVID-19

Researchers receive federal funding to rapidly repurpose FDA-approved drugs for COVID-19

Antidepressant fluoxetine (Prozac) suppresses replication of SARS-CoV-2

Multi-institutional study examines neuroimaging findings in COVID-19 patients

Repeated coughing adversely affects filtering efficiency of face masks

Antibody cocktail with potential to treat COVID-19 identified

New discovery could open door to next generation malaria vaccine

22 nonprofit organizations funded to support the needs of families in response to COVID-19

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

Researchers are strengthening the capacity to assess the risk of COVID-19 in Europe

Awareness campaign aims to alleviate unnecessary fears about calling 9-1-1 in pandemic

Life saving drug found for COVID-19 patients on ventilators

Wealthy hospital taps small craft breweries for financial aid to buy masks, gloves

Health experts link rise in Arizona COVID cases to end of stay-at-home order

Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19

Why improved pneumonia diagnosis is needed now more than ever

COVID-19 health crisis highlights food insecurity among children

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News